Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) EBT Margin (2023 - 2025)

Historic EBT Margin for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 2892.7%.

  • Onconetix's EBT Margin fell 19381200.0% to 2892.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 4090.57%, marking a year-over-year decrease of 9036300.0%. This contributed to the annual value of 2366.62% for FY2024, which is 616414000.0% up from last year.
  • Per Onconetix's latest filing, its EBT Margin stood at 2892.7% for Q3 2025, which was down 19381200.0% from 2227.77% recorded in Q2 2025.
  • Over the past 5 years, Onconetix's EBT Margin peaked at 11861.89% during Q4 2023, and registered a low of 8408.82% during Q1 2025.
  • Over the past 3 years, Onconetix's median EBT Margin value was 1813.65% (recorded in 2024), while the average stood at 531.78%.
  • In the last 5 years, Onconetix's EBT Margin plummeted by -161255700bps in 2024 and then tumbled by -2052200bps in 2025.
  • Onconetix's EBT Margin (Quarter) stood at 11861.89% in 2023, then plummeted by -136bps to 4263.67% in 2024, then soared by 32bps to 2892.7% in 2025.
  • Its EBT Margin stands at 2892.7% for Q3 2025, versus 2227.77% for Q2 2025 and 8408.82% for Q1 2025.